1. Home
  2. Stock quotes
  3. 4D Molecular Therapeutics
  4. Financial Statements
  5. Balance Sheet
  6. Cash and Cash Equivalents
4D Molecular Therapeutics logo
4D Molecular Therapeutics FDMT
$ 7.65 -4.26%
mail-toReport an Error

Quarterly report 2024-Q3
added 11-13-2024

report update icon

4D Molecular Therapeutics Cash and Cash Equivalents 2011-2024 | FDMT

Annual Cash and Cash Equivalents 4D Molecular Therapeutics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
249 M 52.4 M 153 M 277 M - - - - - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
277 M 52.4 M 183 M

Quarterly Cash and Cash Equivalents 4D Molecular Therapeutics

2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
188 M 189 M 276 M 249 M 276 M 236 M - 52.4 M 108 M 113 M 76 M 153 M 91 M 244 M 260 M 277 M 277 M 277 M 277 M 49.7 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
277 M 49.7 M 193 M